A Strong Start to Q1 Against the FY2027 June-Year Plan for Higher Revenue and Profit

For the fiscal year ended June 2026, revenue was ¥4,166 million, operating profit was ¥723 million, ordinary profit was ¥734 million and net income attributable to owners of the parent was ¥518 million. All major profit measures exceeded the previous year. Year on year, revenue increased 9.7%, operating profit 9.9%, ordinary profit 16.3% and net income 18.2%. For the following fiscal year, the company expects revenue of ¥4,402 million, operating profit of ¥790 million, ordinary profit of ¥798 million and net income of ¥555 million.

Cumulative results for the fiscal year ended June 2026 show Q1 revenue of ¥1,000 million and operating profit of ¥150 million, first-half cumulative revenue of ¥2,021 million and operating profit of ¥320 million, and nine-month cumulative revenue of ¥3,057 million and operating profit of ¥509 million. Full-year revenue reached ¥4,166 million and operating profit ¥723 million, securing year-on-year growth in both revenue and profit. Assuming a simple even quarterly allocation, the benchmark for cumulative Q1 of the fiscal year ending June 2027 is ¥1,100.5 million in revenue and ¥197.5 million in operating profit. These are not quarterly targets explicitly set by the company, but reference figures calculated from the full-year forecasts for monitoring purposes.

The company cites additional orders from existing dental institutions, new customer acquisition, orders for orthodontic dental laboratory products and strong sales of digital products as growth drivers. In its earnings presentation, the company breaks down the ¥369 million increase in revenue for the fiscal year ended June 2026 into ¥99 million from digital products, ¥136 million from analog products and ¥133 million from products and other items. This indicates that growth was supported by multiple contributions from an expanding product mix and customer base, rather than by a single large project.

The growth rates planned for the fiscal year ending June 2027 are 5.7% for revenue and 9.3% for operating profit versus the fiscal year ended June 2026, so the plan does not assume double-digit growth. Accordingly, the next earnings release should be assessed not only for year-on-year growth in revenue and profit, but also for progress against the full-year revenue and operating profit plans, any revisions to the full-year forecasts, and whether the growth drivers are translating into recurring orders rather than one-off product sales.